Edition:
United Kingdom

Paion AG (PA8G.DE)

PA8G.DE on Xetra

2.18EUR
4:36pm BST
Change (% chg)

€-0.01 (-0.68%)
Prev Close
€2.20
Open
€2.20
Day's High
€2.22
Day's Low
€2.18
Volume
76,157
Avg. Vol
50,884
52-wk High
€2.85
52-wk Low
€2.01

Chart for

About

Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In... (more)

Overall

Beta: 0.77
Market Cap(Mil.): €162.82
Shares Outstanding(Mil.): 61.12
Dividend: --
Yield (%): --

Financials

  PA8G.DE Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -0.24 -- --
ROI: -46.05 0.73 14.32
ROE: -46.08 1.82 16.04

Earnings vs. Estimates